147 related articles for article (PubMed ID: 38413411)
1. Disruption of the blood-brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. Scientific commentary on "Detection of blood-brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2".
Magro C; Tili E; Nuovo G
Acta Neuropathol; 2024 Feb; 147(1):47. PubMed ID: 38413411
[No Abstract] [Full Text] [Related]
2. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
DeOre BJ; Tran KA; Andrews AM; Ramirez SH; Galie PA
J Neuroimmune Pharmacol; 2021 Dec; 16(4):722-728. PubMed ID: 34687399
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic
Fignani D; Licata G; Brusco N; Nigi L; Grieco GE; Marselli L; Overbergh L; Gysemans C; Colli ML; Marchetti P; Mathieu C; Eizirik DL; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():596898. PubMed ID: 33281748
[TBL] [Abstract][Full Text] [Related]
5. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
[TBL] [Abstract][Full Text] [Related]
6. A review of the mechanisms of blood-brain barrier disruption during COVID-19 infection.
Jamil Al-Obaidi MM; Desa MNM
J Neurosci Res; 2023 Nov; 101(11):1687-1698. PubMed ID: 37462109
[TBL] [Abstract][Full Text] [Related]
7. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
Ahmadi S; Khaledi S
Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis.
Martinez TE; Mayilsamy K; Mohapatra SS; Mohapatra S
Viruses; 2024 May; 16(5):. PubMed ID: 38793666
[TBL] [Abstract][Full Text] [Related]
9. Neurological effects of elevated levels of angiotensin II in COVID-19 patients.
Khezri MR; Ghasemnejad-Berenji M
Hum Cell; 2021 Nov; 34(6):1941-1942. PubMed ID: 34449020
[No Abstract] [Full Text] [Related]
10. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
11. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.
Gorshkov K; Susumu K; Chen J; Xu M; Pradhan M; Zhu W; Hu X; Breger JC; Wolak M; Oh E
ACS Nano; 2020 Sep; 14(9):12234-12247. PubMed ID: 32845122
[TBL] [Abstract][Full Text] [Related]
12. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
13. SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells.
Miao L; Yan C; Chen Y; Zhou W; Zhou X; Qiao Q; Xu Z
Cell Chem Biol; 2023 Mar; 30(3):248-260.e4. PubMed ID: 36889309
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
Lu J; Sun PD
J Biol Chem; 2020 Dec; 295(52):18579-18588. PubMed ID: 33122196
[TBL] [Abstract][Full Text] [Related]
15. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
16. Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).
Bejoy J; Williams CI; Cole HJ; Manzoor S; Davoodi P; Battaile JI; Kaushik A; Nikolaienko SI; Brelidze TI; Gychka SG; Suzuki YJ
Arch Biochem Biophys; 2023 Oct; 748():109769. PubMed ID: 37769892
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
Morgun AV; Salmin VV; Boytsova EB; Lopatina OL; Salmina AB
Sovrem Tekhnologii Med; 2021; 12(6):98-108. PubMed ID: 34796023
[TBL] [Abstract][Full Text] [Related]
18. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.
Shu CJ; Huang X; Tang HH; Mo DD; Zhou JW; Deng C
Zool Res; 2021 Mar; 42(2):170-181. PubMed ID: 33738989
[TBL] [Abstract][Full Text] [Related]
19. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
Jafary F; Jafari S; Ganjalikhany MR
Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
Stüdle C; Nishihara H; Wischnewski S; Kulsvehagen L; Perriot S; Ishikawa H; Schroten H; Frank S; Deigendesch N; Du Pasquier R; Schirmer L; Pröbstel AK; Engelhardt B
Fluids Barriers CNS; 2023 Oct; 20(1):76. PubMed ID: 37875964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
